Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

5.3K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.6K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.6K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

1.7K
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.7K
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

3
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
3
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

768
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
768

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-resolution CT findings of culture-confirmed enterococcal pneumonia: A two-center retrospective study.

Tuberkuloz ve toraks·2026
Same author

Twelve-month smoking cessation outcomes following immediate referral in people who smoke with chronic airway diseases: a randomized study.

Addiction science & clinical practice·2026
Same author

Governing Generative AI in Healthcare: A Normative Conceptual Framework for Epistemic Authority, Trust, and the Architecture of Responsibility.

Healthcare (Basel, Switzerland)·2026
Same author

Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD).

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2026
Same author

Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients.

BMC pulmonary medicine·2026
Same author

Post-COVID-19 Physical Activity and Symptom Burden in Patients with Asthma and COPD Compared with Individuals Without Chronic Disease: A Multicenter Cross-Sectional Study.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Apr 18, 2026

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.6K

Acute inhalation injury.

Metin Gorguner1, Metin Akgun1

  • 1Atatürk University, Faculty of Medicine, Department of Chest Diseases, Erzurum, Turkey.

The Eurasian Journal of Medicine
|January 23, 2015
PubMed
Summary
This summary is machine-generated.

Short-term exposure to toxic inhaled substances can cause acute inhalation injury (AII) affecting the lungs. Factors like substance properties and individual susceptibility influence severity, potentially leading to complications or death.

Keywords:
Acute inhalation injuryDiagnosisEpidemiologyLungPrognosisTreatment

More Related Videos

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

10.3K
Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
04:10

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Published on: December 5, 2025

460

Related Experiment Videos

Last Updated: Apr 18, 2026

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.6K
Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

10.3K
Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
04:10

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Published on: December 5, 2025

460

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Environmental Health

Background:

  • Inhaled substances can damage the pulmonary epithelium, causing respiratory issues from mild symptoms to severe illness.
  • Acute inhalation injury (AII) is a recognized condition occurring in various settings, including homes, workplaces, and through environmental exposure.
  • Individual susceptibility plays a role in AII development.

Purpose of the Study:

  • To discuss the pulmonary effects of short-term (minutes to hours) exposure to toxic inhaled substances.
  • To highlight the factors influencing the severity and location of lung injury from inhaled toxins.

Main Methods:

  • Literature review and synthesis of existing data on acute inhalation injury.
  • Analysis of factors contributing to AII, including substance characteristics and exposure scenarios.

Main Results:

  • Inhaled substance properties (solubility, size, chemical nature) significantly impact AII severity and affected lung regions.
  • AII can range from mild, short-term symptoms to severe, life-threatening conditions with potential long-term complications.
  • Exposure can occur in diverse environments, not limited to specific high-risk groups.

Conclusions:

  • Short-term inhalation of toxic substances poses a significant risk to lung health.
  • Understanding the interplay between inhaled agents, exposure conditions, and host factors is crucial for managing AII.
  • Prompt recognition and management are essential to prevent severe outcomes and long-term pulmonary sequelae.